| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.00075 | 1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |